tiprankstipranks
Trending News
More News >
Protagonist Therapeutics Inc (PTGX)
:PTGX
US Market
Advertisement

Protagonist Therapeutics (PTGX) Ownership - Who Owns Protagonist Therapeutics?

Compare
729 Followers

Protagonist Therapeutics (PTGX) Ownership Overview

1.62%15.77%49.61%21.79%11.20%
49.61% Other Institutional Investors
21.79% ETFs
11.20% Public Companies and
Individual Investors
The ownership structure of Protagonist Therapeutics (PTGX) stock is a mix of institutional, retail, and individual investors. Approximately 87.18% of the company’s stock is owned by Institutional Investors, 1.62% is owned by Insiders, and 11.20% is owned by Public Companies and Individual Investors.
The ownership structure of Protagonist Therapeutics (PTGX) stock is a mix of institutional, retail, and individual investors. Approximately 65.38% of the company’s stock is owned by Institutional Investors, 1.62% is owned by Insiders, and 21.79% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Nov 19, 2025
xxxxxxxxxxxxx
$229896
Jul 28, 2025
xxxxxxxxxxxxx
$570534
Jul 23, 2025
xxxxxxxxxxxxx
$2880044
Jun 11, 2025
xxxxxxxxxxxxx
$1125400

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Sep 30, 2025
xxxxxxxxxxxxx
$62510
Sep 30, 2025
xxxxxxxxxxxxx
$1128579
Sep 30, 2025
xxxxxxxxxxxxx
$1395030
Sep 30, 2025
xxxxxxxxxxxxx
$10608871

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
6,659,394Institution10.65%563,451,326
6,196,006Institution9.91%524,244,068
3,326,747Institution5.32%281,476,064
2,942,127Institution4.71%248,933,365
1,974,581Institution3.16%167,069,298
1,438,247Institution2.30%121,690,079
1,139,854Institution1.82%96,443,047
1,030,134Institution1.65%87,159,638
685,458Institution1.10%57,996,601
638,095Institution1.02%53,989,218

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
2,942,127Institution4.71%248,933,365
685,458Institution1.10%57,996,601
638,095Institution1.02%53,989,218
625,890Institution1.00%52,956,553
430,909Institution0.69%36,459,210
429,113Institution0.69%36,307,251
397,291Institution0.64%33,614,792
371,363Institution0.59%31,421,023
343,387Institution0.55%29,053,974
328,744Institution0.53%27,815,030

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
3,428,940Institution5.48%290,122,613
1,946,194Institution3.11%129,285,667
1,436,975Institution2.30%121,582,455
1,048,339Institution1.68%87,263,738
626,060Institution1.00%41,589,166
509,524Institution0.82%43,110,826
506,298Institution0.81%42,144,246
502,292Institution0.80%42,498,926
384,324Institution0.61%32,517,654
286,754Institution0.46%23,869,403

FAQ

Who Owns Protagonist Therapeutics Inc (PTGX)?
According to the latest TipRanks data, approximately 49.61% of the company's stock is held by institutional investors, 1.62% is held by insiders, and 11.20% is held by retail investors.
    What percentage of Protagonist Therapeutics Inc (PTGX) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 49.61% of Protagonist Therapeutics Inc (PTGX) stock is held by institutional investors.
      What percentage of Protagonist Therapeutics Inc (PTGX) stock is held by retail investors?
      According to the latest TipRanks data, approximately 11.20% of Protagonist Therapeutics Inc (PTGX) stock is held by retail investors.
        Who owns the most shares of Protagonist Therapeutics Inc (PTGX)?
        iShares owns the most shares of Protagonist Therapeutics Inc (PTGX).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis